Pulmonary capillary hemangiomatosis in Chinese patients without EIF2AK4 mutations

• Published in: Pathology, research and practice research and practice, 2020-09, Vol.216 (9), p.153100-153100, Article 153100
• Main Authors: Li, Yuqin, Gu, Yingying, Hong, Cheng, Deng, Yu, Chen, Zhucheng, Jiang, Juhong
• Format: Article
• Language: English
• Subjects: EIF2AK4; Pulmonary capillary hemangiomatosis; Pulmonary hypertension; Pulmonary veno-occlusive disease
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2020.153100

Pulmonary capillary hemangiomatosis (PCH) is a very rare and refractory pulmonary vascular disease that causes pulmonary hypertension. Differentiation of PCH from idiopathic pulmonary arterial hypertension (iPAH) is essential because treatment and prognosis can vary greatly between these two diseases. A 20-year-old female and a 33-year-old male both presented with progressive exertional dyspnea and cough. High-resolution computed tomography (HRCT) showed bilateral, diffuse, ill-defined centrilobular nodules of ground-glass opacity, without subpleural thickened septal lines or mediastinal lymphadenopathy. Both cases showed clinical and imaging features characteristic of pulmonary veno-occlusive disease (PVOD) or PCH. The entire EIF2AK4 coding sequence was detected with Sanger sequencing, and no pathogenic EIF2AK4 mutations were identified in either case. Video-assisted thoracoscopic surgery (VATS) was safely performed in both cases, and histopathological examinations of biopsies showed that both patients had PCH. Two patients presented with clinical and imaging characteristics suspicious for PVOD/PCH. Despite having no pathogenic EIF2AK4 mutations, both were diagnosed with PCH by VATS lung biopsies. The diagnostic distinction of PCH is important to prompt timely evaluations of patients who may need lung transplantations.